Jeffrey A. Leerink

Jeffrey A. Leerink is Chairman and Chief Executive Officer of Leerink Partners, the largest investment bank dedicated exclusively to healthcare. Since its founding three decades ago, the Firm has grown into a market-leading franchise recognized for its strength in equity research, equity capital markets, and M&A advisory. Under Mr. Leerink’s leadership, Leerink Partners has earned a reputation as a trusted partner to healthcare companies and investors, helping them achieve their most important strategic and financial objectives.

Mr. Leerink co-founded MEDACorp in 1996, a provider of insights on the commercial potential of biotherapeutics and medical devices for healthcare companies and investors. Today, MEDACorp remains an integral source of industry and market intelligence for Leerink Partners and its clients. In 2008, he co-founded Humedica, Inc., a clinical intelligence company that was acquired by Optum, a subsidiary of UnitedHealth Group, in 2013. He later founded Leerink Capital Partners, a healthcare-focused, multi-strategy asset management firm that launched Leerink Transformation Partners and Leerink Revelation Partners.

In 2019, Mr. Leerink led the sale of Leerink Partners to Silicon Valley Bank and subsequently served as CEO of SVB Securities. In 2023, he led a management buyout that restored the Firm’s independence.

Mr. Leerink is committed to advancing healthcare and education through both his professional and philanthropic endeavors. He is Vice Chairman of the Harvard Medical School Board of Fellows and serves on the President’s Board of Advisors at Mass General Brigham. He is also a former Chairman of the Board of Big Brothers Big Sisters of Eastern Massachusetts Bay.

Mr. Leerink holds a B.A. in Economics from Union College.